Davies BE - Search Results

1

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks.

van Warmerdam LJ, Verweij J, Schellens JH, Rosing H, Davies BE, de Boer-Dennert M, Maes RA, Beijnen JH. van Warmerdam LJ, et al. Among authors: davies be. Cancer Chemother Pharmacol. 1995;35(3):237-45. doi: 10.1007/BF00686554. Cancer Chemother Pharmacol. 1995. PMID: 7805183 Free article. Clinical Trial.

2

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor.

Schellens JH, Creemers GJ, Beijnen JH, Rosing H, de Boer-Dennert M, McDonald M, Davies B, Verweij J. Schellens JH, et al. Br J Cancer. 1996 May;73(10):1268-71. doi: 10.1038/bjc.1996.243. Br J Cancer. 1996. PMID: 8630291 Free PMC article. Clinical Trial.

3

High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.

Rosing H, Doyle E, Davies BE, Beijnen JH. Rosing H, et al. Among authors: davies be. J Chromatogr B Biomed Appl. 1995 Jun 9;668(1):107-15. doi: 10.1016/0378-4347(95)00054-m. J Chromatogr B Biomed Appl. 1995. PMID: 7550966

4

Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.

van Warmerdam LJ, ten Bokkel Huinink WW, Rodenhuis S, Koier I, Davies BE, Rosing H, Maes RA, Beijnen JH. van Warmerdam LJ, et al. Among authors: davies be. J Clin Oncol. 1995 Jul;13(7):1768-76. doi: 10.1200/JCO.1995.13.7.1768. J Clin Oncol. 1995. PMID: 7602366 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure.

van Warmerdam LJ, Creemers GJ, Rodenhuis S, Rosing H, de Boer-Dennert M, Schellens JH, ten Bokkel Huinink WW, Davies BE, Maes RA, Verweij J, Beijnen JH. van Warmerdam LJ, et al. Among authors: davies be. Cancer Chemother Pharmacol. 1996;38(3):254-60. doi: 10.1007/s002800050479. Cancer Chemother Pharmacol. 1996. PMID: 8646800 Clinical Trial.

6

The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.

Davies BE, Minthorn EA, Dennis MJ, Rosing H, Beijnen JH. Davies BE, et al. Pharm Res. 1997 Oct;14(10):1461-5. doi: 10.1023/a:1012189225880. Pharm Res. 1997. PMID: 9358562

7

Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients.

Brocks DR, Freed MI, Martin DE, Sellers TS, Mehdi N, Citerone DR, Boppana V, Levitt B, Davies BE, Nemunaitis J, Jorkasky DK. Brocks DR, et al. Among authors: davies be. Pharm Res. 1996 May;13(5):794-7. doi: 10.1023/a:1016020221300. Pharm Res. 1996. PMID: 8860439

8

Exploring various measures of the area under the curve for the assessment of dose-proportionality and estimation of bioavailability.

Brocks DR, Minthorn EA, Davies BE. Brocks DR, et al. Among authors: davies be. J Pharm Pharmacol. 2024 Mar 4;76(3):245-256. doi: 10.1093/jpp/rgae004. J Pharm Pharmacol. 2024. PMID: 38262451

9

Functional genomics in Spiralia.

Martín-Zamora FM, Davies BE, Donnellan RD, Guynes K, Martín-Durán JM. Martín-Zamora FM, et al. Among authors: davies be. Brief Funct Genomics. 2023 Nov 17;22(6):487-497. doi: 10.1093/bfgp/elad036. Brief Funct Genomics. 2023. PMID: 37981859 Free PMC article.

10

Erratum.

Korfali SI, Davies BE. Korfali SI, et al. Among authors: davies be. Environ Geochem Health. 2023 Jun;45(Suppl 1):1. doi: 10.1007/s10653-006-1913-1. Environ Geochem Health. 2023. PMID: 37188990 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page